Article in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 4 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
8 authors at 1 institution in 1 country.
Mariana Carla de OliveiraPostgraduate Program in Pharmaceutical Sciences, Laboratory of Research and Development of Drug Delivery Systems, Department of Pharmacy, State University of Maringa, Av. Colombo 5790, Maringa 87020-900, PR, Brazil.ORCID 0000-0002-7821-4469
Rodolfo Bento BalbinotPostgraduate Program in Biological Sciences, Laboratory of Technological Innovation in the Development of Pharmaceuticals and Cosmetics, Department of Health Basic Sciences, State University of Maringa, Av. Colombo 5790, Maringa 87020-900, PR, Brazil.ORCID 0000-0001-8245-0950
Mônica Villa NovaPostgraduate Program in Pharmaceutical Sciences, Laboratory of Research and Development of Drug Delivery Systems, Department of Pharmacy, State University of Maringa, Av. Colombo 5790, Maringa 87020-900, PR, Brazil.ORCID 0000-0003-1221-7680
Renato Sonchini GonçalvesResearch Nucleus in Photodynamic Systems and Nanomedicine, Department of Chemistry, State University of Maringa, Av. Colombo 5790, Maringa 87020-900, PR, Brazil.ORCID 0000-0003-2701-6101
Danielle Lazarin BidóiaPostgraduate Program in Biological Sciences, Laboratory of Technological Innovation in the Development of Pharmaceuticals and Cosmetics, Department of Health Basic Sciences, State University of Maringa, Av. Colombo 5790, Maringa 87020-900, PR, Brazil.
Wilker CaetanoResearch Nucleus in Photodynamic Systems and Nanomedicine, Department of Chemistry, State University of Maringa, Av. Colombo 5790, Maringa 87020-900, PR, Brazil.
Celso Vataru NakamuraPostgraduate Program in Biological Sciences, Laboratory of Technological Innovation in the Development of Pharmaceuticals and Cosmetics, Department of Health Basic Sciences, State University of Maringa, Av. Colombo 5790, Maringa 87020-900, PR, Brazil.ORCID 0000-0002-9911-7369
Marcos Luciano BruschiPostgraduate Program in Pharmaceutical Sciences, Laboratory of Research and Development of Drug Delivery Systems, Department of Pharmacy, State University of Maringa, Av. Colombo 5790, Maringa 87020-900, PR, Brazil.ORCID 0000-0002-4838-5742
Universidade Estadual de Maringá · BR
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
Leishmaniasis is a disease caused by protozoa species of the
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Development of Environmentally Responsive Self-Emulsifying System Containing Copaiba Oil-Resin for Leishmaniasis Oral Treatment. · full record | OpenQuestion